Staphylococcus aureus small colony variants: a challenge to microbiologists and clinicians

International Journal of Antimicrobial Agents
Christof von Eiff

Abstract

The pathogen Staphylococcus aureus may use various strategies to resist antibiotic therapy. One of these strategies is the formation of small colony variants (SCVs), a naturally occurring, slow-growing subpopulation with distinctive phenotypic characteristics and pathogenic traits. SCVs are defined by mostly non-pigmented and non-haemolytic colonies ca. 10 times smaller than the parent strain. In the past decade, many reports and prospective studies have supported a pathogenic role for these variants in patients with persistent and/or recurrent infections. The tiny size of clinical and experimentally derived SCVs on solid agar is often due to auxotrophy for hemin and/or menadione, two compounds involved in the biosynthesis of electron transport chain components. The morphological and physiological features of SCVs present a challenge to clinical microbiologists in terms of recovery of organisms, their identification and susceptibility testing. Based on the knowledge that SCVs may persist intracellularly, treatment including antimicrobial agents with intracellular antistaphylococcal activity appears appropriate. SCVs potentially use the upregulated arginine deiminase pathway to produce ATP or, through ammonia production, to coun...Continue Reading

References

Jan 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A ProctorR D Arbeit
Dec 24, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C von EiffG Peters
Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A ProctorG Peters
Oct 14, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A Proctor, G Peters
Feb 22, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Franz-Josef SchmitzMark E. Jones
Jan 14, 2003·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Nicole BaumertHans-Georg Sahl
Nov 18, 2003·Journal of Bacteriology·Christian KohlerSusanne Engelmann
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Christof von EiffGeorg Peters
Jan 24, 2006·Infection and Immunity·Costi D SifriChristof von Eiff
Mar 17, 2006·Nature Reviews. Microbiology·Richard A ProctorGeorg Peters
Sep 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Parham SendiWerner Zimmerli

❮ Previous
Next ❯

Citations

Jan 22, 2011·Folia Microbiologica·O Melter, B Radojevič
Jun 17, 2011·Animal Health Research Reviews·Heba AtallaBonnie Mallard
May 31, 2012·Proceedings of the National Academy of Sciences of the United States of America·Longzhu CuiKeiichi Hiramatsu
May 24, 2012·The Journal of Antimicrobial Chemotherapy·Keith Poole
Mar 15, 2013·The Journal of Antimicrobial Chemotherapy·Laetitia G GarciaFrançoise Van Bambeke
Sep 10, 2008·Antimicrobial Agents and Chemotherapy·Jonas LannergårdDiarmaid Hughes
Mar 9, 2010·Journal of Bacteriology·Rosmarie GauppFriedrich Götz
Jun 18, 2010·Journal of Clinical Microbiology·Carmen Gómez-GonzálezFernando Chaves
Sep 19, 2012·Journal of Molecular Microbiology and Biotechnology·Sabrina LechnerRalph Bertram
Feb 1, 2013·Journal of Molecular Microbiology and Biotechnology·Sabrina LechnerRalph Bertram
Jun 9, 2009·Genome Biology·Shiri FreilichEytan Ruppin
Mar 30, 2011·Journal of Visualized Experiments : JoVE·Andrew M Edwards, Ruth C Massey
Feb 5, 2014·Current Opinion in Infectious Diseases·Kordo SaeedNusreen Ahmad
Dec 24, 2013·Enfermedades infecciosas y microbiología clínica·Fernando Chaves
May 25, 2011·Expert Review of Vaccines·Jane BroughanAnnaliesa S Anderson
Sep 24, 2013·Enfermedades infecciosas y microbiología clínica·Mercedes Delgado-ValverdeAlvaro Pascual-Hernández
Apr 16, 2013·Enfermedades infecciosas y microbiología clínica·Carmen AspirozCarla Toyas
Mar 15, 2012·The Surgical Clinics of North America·Philip S Barie
Sep 11, 2009·Proteomics·Stephan MichalikMichael Hecker
May 8, 2013·Journal of Veterinary Internal Medicine·A C DavenportE B Breitschwerdt
Oct 1, 2011·Environmental Microbiology Reports·Andreas J BäumlerJosep Casadesús
Apr 9, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Server YagciGulsen Hascelik
Nov 30, 2010·Acta Orthopaedica·Jaime EstebanEnrique Gómez-Barrena
Mar 31, 2015·Journal of Biomedical Informatics·Ana Margarida SousaAnália Lourenço
Mar 19, 2015·Journal of Proteomics·Mousa M AlreshidiTim K Roberts
Nov 6, 2009·International Journal of Medical Microbiology : IJMM·John A Wright, Sean P Nair
May 8, 2015·Journal of Laboratory Physicians·Mohamed O AhmedMohamed S Agdih
Mar 18, 2015·The American Journal of Cardiology·Avish NagpalM Rizwan Sohail
Aug 30, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S LemaireP C Appelbaum
Feb 16, 2016·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Otto S KluinHenny C van der Mei
Oct 9, 2015·Microbiology Insights·Benjamin E JohnsSarah E Maddocks
Feb 16, 2018·Clinical Microbiology Reviews·Nicola KavanaghSteven W Kerrigan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
R A ProctorR D Arbeit
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Parham SendiWerner Zimmerli
© 2021 Meta ULC. All rights reserved